The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor
Open accessAbstract
Background NKT cells play an important role in anti-tumor immunity. Alpha-galactosylceramide (α-GalCer), a synthetic glycolipid is presented to natural killer T (NKT) cells by most antigen-presenting cells through CD1d molecules leading to activation of NKT cells. However, the precise mechanisms of how α-GalCer-activated NKT regulate the polarization of the macrophages and effector T cells in the solid tumor are not studied adequately. Methods We induced solid tumor in C57BL/6 mice by subcutaneous injection of B16F10 cell line (1 X 106 cells) and monitored the tumor growth. Animals were given an intraperitoneal injection of α-GalCer (2 μg/injection) in 200 μl PBS on day + 1, + 5, + 10, + 15, and + 20 (with respect to tumor cell injection). Immune cells were characterized using flow cytometry and immunofluorescence staining. NK cells, Gr1+ cells, and F4/80+ macrophages in the mice were depleted by intravenous injection of cell-specific antibodies. Statistical analysis was performed using Student’s t-test or one-way ANOVA. Results Our results showed that intratumoral NKT cells have a lower frequency of CD69, CD25, CD122, and IFN-γR expression; produced less inflammatory cytokines such as IFN-γ, TNF-α, and GM-CSF; higher frequency CD62L+ NKT cells; and also showed reduced proliferation as compared to the splenic NKT cells. Mice treated with α-GalCer showed a significantly increased frequency of IFN-γ-producing NKT cells, CD8+ T cells, and effector Th1 cells. Depletion of NK cells in α-GalCer-treated mice showed a lower frequency of IFN-γ-producing CD4+ and CD8+ T cells in the tumor and prevented the α-GalCer-induced tumor growth. NKT cell activation with α-GalCer treatment significantly increased the iNOS+CD206− M1-macrophages and reduced the iNOS−CD206+ M2-macrophages in the spleen and tumor, and depletion of F4/80+ macrophages prevented the α-GalCer-induced reduction in the tumor growth. Conclusions We showed that activation of NKT cell with α-GalCer modulates the frequency of M1-macrophages and effector Th1 cells in the secondary lymphoid tissues and tumor microenvironment and inhibit tumor growth. The finding suggests that activation of NKT cells with α-GalCer may provide an effective anti-cancer outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“iNOS is an intermediate metabolite of activated M1 macrophages involved in antibacterial-related biological processes (Orecchioni et al., 2019;Paul et al., 2019).”
From Nanosilver alleviates foreign body reaction and facilitates wound repair by regulating macrophage polarization (2023) · cites this paper as Paul et al., 2019
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067 · cited 2×
“In contrast, M2 macrophages secrete Th2-type cytokines such as IL4, IL-10, IL-13, and TGF-β, and show a pro-tumorigenic phenotype [21].”
BackgroundCD1 Recognition by Mouse NK1 + T Lymphocytes
Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R., & Brutkiewicz, R. R. (1995) · Science · doi:10.1126/science.7538697 · Cited by 914
Going both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01124 · Cited by 825
Self-citationIdentification of an IL-17–producing NK1.1neg iNKT cell population involved in airway neutrophilia
Michel, M.-L., Keller, A. C., Paget, C., Fujio, M., Trottein, F., Savage, P. B., Wong, C.-H., Schneider, E., Dy, M., & Leite-de-Moraes, M. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061551 · Cited by 617
Giaccone, G., Punt, C. J. A., Ando, Y., Ruijter, R., Nishi, N., Peters, M. E. W. J., Blomberg, B. M. E. V., Scheper, R. J., van der Vliet, H. J., van den Eertwegh, A. J. M., et al. (2002) · PubMed · Cited by 506
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
Coquet, J. M., Chakravarti, S., Kyparissoudis, K., McNab, F. W., Pitt, L. A., McKenzie, B. S., Berzins, S. P., Smyth, M. J., & Godfrey, D. I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801631105 · Cited by 463
Glycolipid antigen induces long-term natural killer T cell anergy in mice
Parekh, V. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24762 · Cited by 458
Dhodapkar, M. V., Geller, M. D., Chang, D. H., Shimizu, K., Fujii, S.-I., Dhodapkar, K. M., & Krasovsky, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021650 · Cited by 425
Cited by
Roles of IFN-γ in tumor progression and regression: A review
Jorgovanovic, D., Song, M., Wang, L., & Zhang, Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00228-x · Cited by 1,234
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments
Xu, J., Ding, L., Mei, J., Hu, Y., Kong, X., Dai, S., Bu, T., Xiao, Q., & Ding, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02325-5 · Cited by 389
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044002 · Cited by 263
Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials
Zhang, W., Wang, M., Ji, C., Liu, X., Gu, B., & Dong, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116930 · Cited by 178
Role of serotonin receptor signaling in cancer cells and anti-tumor immunity
Karmakar, S., & Lal, G. (2021) · Theranostics · doi:10.7150/thno.55986 · Cited by 196
Self-citation
Metadata
- Authors
- Paul, S., Chhatar, S., Mishra, A., & Lal, G.
- Affiliations
- National Centre for Cell Science (IN)
- Corresponding author
- Lal, Girdhari
- Venue
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Published
- 2019-08-06
- Volume
- 7
- Issue
- 1
- Pages
- 208-208
- ISSN
- 2051-1426 (ISSN-L)
- PMC
- PMC6685184
- OpenAlex
- W2964572246
- Cited by
- 150
- References
- 64
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 27 · 2023: 27 · 2022: 22 · 2021: 21 · 2020: 5 · 2019: 1
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Journal for ImmunoTherapy of Cancer (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Science and Engineering Research Board (EMR/2016/007108)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- NKT cells, alpha-galactosylceramide, CD1d, macrophage polarization, M1 macrophages, M2 macrophages, inducible nitric oxide synthase, CD206, tumor growth, antitumor immunity, NK cell depletion, CD8+ T cells, Th1 cells, interferon-gamma, B16F10 melanoma
- MeSH terms
- Mannose Receptor, Animals, Lymphocyte Activation, Macrophages, Male, Melanoma, Experimental, Mice, Inbred C57BL, Receptors, Cell Surface, Lectins, C-Type, Mannose-Binding Lectins, Mice, Nitric Oxide Synthase Type II, Natural Killer T-Cells, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor. https://app.cochat.ai/papers/10.1186/s40425-019-0697-7
- The paper
- Paul, S., Chhatar, S., Mishra, A., & Lal, G. (2019). Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1186/s40425-019-0697-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.